Skip to main content

LGL Partners, LLC

SEC CIK
0001653202
Latest filing
Jul 27, 2026

AVTX holding history

Avalo Therapeutics, Inc. in every 13F filed by LGL Partners, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVTX overviewAll 13F holders of AVTXFull Q2 2026 holdings

Shares (Q1 2022)
0
Sold out in Q1 2022
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q4 2021
Holdings of AVTX by LGL Partners, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20220$00.0%−28,850−100.0%Sold outHolders
Q4 202128,850$49.0K<0.1%+28,850NewHolders